Avior Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.31M Buy
2,950
+648
+28% +$288K 0.05% 239
2025
Q1
$1.12M Sell
2,302
-667
-22% -$323K 0.04% 246
2024
Q4
$1.2M Buy
2,969
+436
+17% +$176K 0.04% 251
2024
Q3
$1.18M Buy
2,533
+113
+5% +$52.6K 0.05% 257
2024
Q2
$1.13M Sell
2,420
-686
-22% -$322K 0.05% 244
2024
Q1
$1.3M Buy
3,106
+384
+14% +$161K 0.06% 234
2023
Q4
$1.11M Buy
2,722
+48
+2% +$19.5K 0.07% 193
2023
Q3
$930K Hold
2,674
0.06% 207
2023
Q2
$941K Hold
2,674
0.06% 208
2023
Q1
$842K Sell
2,674
-251
-9% -$79.1K 0.06% 224
2022
Q4
$845K Sell
2,925
-112
-4% -$32.3K 0.06% 210
2022
Q3
$878K Sell
3,037
-119
-4% -$34.4K 0.07% 183
2022
Q2
$889K Sell
3,156
-964
-23% -$272K 0.09% 160
2022
Q1
$1.07M Sell
4,120
-630
-13% -$164K 0.09% 155
2021
Q4
$1.04M Hold
4,750
0.09% 191
2021
Q3
$861K Buy
4,750
+2,430
+105% +$440K 0.07% 209
2021
Q2
$467K Buy
2,320
+1,347
+138% +$271K 0.05% 314
2021
Q1
$209K Hold
973
0.02% 397
2020
Q4
$229K Buy
973
+246
+34% +$57.9K 0.03% 369
2020
Q3
$197K Sell
727
-173
-19% -$46.9K 0.03% 378
2020
Q2
$261K Sell
900
-389
-30% -$113K 0.04% 350
2020
Q1
$306K Sell
1,289
-26
-2% -$6.17K 0.06% 267
2019
Q4
$287K Buy
1,315
+26
+2% +$5.68K 0.05% 330
2019
Q3
$218K Buy
1,289
+5
+0.4% +$846 0.04% 353
2019
Q2
$235K Buy
+1,284
New +$235K 0.04% 338
2018
Q2
Sell
-9
Closed -$1K 861
2018
Q1
$1K Hold
9
﹤0.01% 766
2017
Q4
$1K Buy
+9
New +$1K ﹤0.01% 770